Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.45 USD | +5.05% | +17.76% | +39.31% |
04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
04-18 | Verastem Oncology Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.31% | 276M | |
+8.39% | 105B | |
-0.96% | 104B | |
+5.50% | 22.94B | |
-12.29% | 22.34B | |
-6.45% | 19.25B | |
-39.98% | 17.08B | |
-9.37% | 16.96B | |
+8.04% | 14.16B | |
+38.45% | 12.63B |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- Verastem : HC Wainwright Adjusts Verastem's Price Target to $5 from $4, Keeps Buy Rating